A nationwide analysis of clinical trial participation for common hepato-pancreato-biliary malignancies demonstrates survival advantages for subsets of trial patients but disparities in and infrequency of enrollment-Reference-Cited by-同舟云学术

A nationwide analysis of clinical trial participation for common hepato-pancreato-biliary malignancies demonstrates survival advantages for subsets of trial patients but disparities in and infrequency of enrollment

Published:2022-08 Issue:8 Volume:24 Page:1280-1290
ISSN:1365-182X
Container-title:HPB
language:en
Short-container-title:HPB

Author:

Elshami Mohamedraed^ORCID,Hue Jonathan J.^ORCID,Hoehn Richard S.^ORCID,Rothermel Luke D.,Bajor David,Mohamed Amr,Selfridge Jennifer E.,Chavin Kenneth D.,Ammori John B.,Hardacre Jeffrey M.,Winter Jordan M.,Ocuin Lee M.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference41 articles.

1. Cancer statistics, 2021;Siegel;CA A Cancer J Clin,2021

2. Cancer trials versus the real world in the United States;Al-Refaie;Ann Surg,2011

3. Participation of Black Americans in cancer clinical trials: current challenges and proposed solutions;Awidi;JCO Oncol Pract,2021

4. Disparities in participation in cancer clinical trials in the United States : a symptom of a healthcare system in crisis;Colon-Otero;Cancer,2008

5. Use of the national cancer data base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of surgeons oncology group (ACOSOG) special population committee;Newman;Cancer,2006

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of Localized Intrahepatic Cholangiocarcinoma: What Exactly is the ‘Evidence’?;Annals of Surgical Oncology;2024-08-05

2. Differences in receipt of guideline-compliant care and survival for early-onset versus average-onset biliary tract cancers;Surgical Oncology Insight;2024-03

3. Racial and Ethnic Disparities in Clinical Trial Enrollment Among Women With Gynecologic Cancer;JAMA Network Open;2023-12-07

4. Average treatment effect of facility hepatopancreatobiliary malignancy case volume on survival of patients with nonoperatively managed hepatobiliary malignancies;Surgery;2023-02

5. Average treatment effect of facility hepatopancreatobiliary cancer volume on survival of non-resected pancreatic adenocarcinoma;HPB;2022-11